Neuroimaging standards for research into small vessel disease—advances since 2013Marco Duering, Hugh S. Markus, Walter H. Backes et al.|The Lancet Neurology|2023Cited by 962
Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trialMichael D. Hill, Cameron McDougall, Mayank Goyal et al.|The Lancet|2020Cited by 623
Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined SourceKanjana Perera, Grant Stotts, Danielle de Sá Boasquevisque et al.|JAMA Neurology|2022Cited by 89
Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous ThrombosisThalia S. Field, Kenneth Butcher, Vanessa Dizonno et al.|Stroke|2023Cited by 70
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-AnalysisShadi Yaghi, Brian Mac Grory, Ian J. Saldanha et al.|Stroke|2022Cited by 49